Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ergosterol gene expression in wild-type and ergosterol-deficient mutants of Candida albicans.

Medical mycology - 1 Aug 2004

Pierson C A, Eckstein J, Barbuch R, Bard M

Abstract excerpt

The ergosterol pathway is the major target of the azole antifungals. We have developed a panel of five viable ergosterol biosynthetic mutants (erg2, erg3, erg6, erg11 and erg24) and have performed Northern analyses to study transcriptional regulation using probes to four ergosterol biosynthetic genes (ERG2, ERG7, ERG11 and ERG25), as well as probes to two additional genes encoding ergosterol cytochrome coenzymes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Candida albicans
Share to Culture Media
Share to Ergosterol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fungal Proteins

Share to Gene Expression Regulation, Fungal

Share to RNA, Fungal

Share to RNA, Messenger

Share to Transcription, Genetic

Source

Identifiers

PMID: 15473366
DOI: 10.1080/13693780410001712016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ergosterol gene expression in wild-type and ergosterol-deficient mutants of Candida albicans.PMID 15473366Read ↗

The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs.Semantic proximity Read ↗

Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA MicroarraySemantic proximity Read ↗

Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.Semantic proximity Read ↗

cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p.Semantic proximity Read ↗

Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site.Semantic proximity Read ↗

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.Semantic proximity Read ↗

Azole-Resistant Alleles of ERG11 in Candida glabrata Trigger Activation of the Pdr1 and Upc2A Transcription Factors.Semantic proximity Read ↗

Multiple mechanisms impact fluconazole resistance of mutant Erg11 proteins in Candida glabrataSemantic proximity Read ↗

Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans.Semantic proximity Read ↗

Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicansSemantic proximity Read ↗

The sterol C-24 methyltransferase encoding gene, erg6, is essential for viability of Aspergillus speciesSemantic proximity Read ↗

Loss of Upc2p-Inducible ERG3 Transcription Is Sufficient To Confer Niche-Specific Azole Resistance without Compromising Candida albicans PathogenicitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.